Mild Cognitive Impairment: Aging to Alzheimer's DiseaseRonald C. Petersen Oxford University Press, 9 jan. 2003 - 288 sidor What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions about this condition and its underlying neuropathology remain open, full clinical trials are currently underway worldwide aimed at preventing the progression from MCI to Alzheimer's disease. This book addresses the spectrum of issues involved in mild cognitive impairment, and includes chapters on clinical studies, neuropsychology, neuroimaging, neuropathology, biological markers, diagnostic approaches, and treatment. It is intended for clinicians, researchers, and students interested in aging and cognition, among them neurologists, psychiatrists, geriatricians, clinical psychologists, and neuropsychologists. |
Innehåll
1 | |
2 CLINICAL FEATURES | 15 |
3 NEUROPSYCHIATRIC SYMPTOMS | 41 |
4 NORMATIVE NEUROPSYCHOLOGY | 63 |
5 OPTIMIZING COGNITIVE TEST NORMS FOR DETECTION | 89 |
6 MAGNETIC RESONANCE IMAGING | 105 |
7 FUNCTIONAL IMAGING | 133 |
8 SPECTRUM OF PATHOLOGY | 149 |
9 NEUROPATHOLOGICAL CHANGES IN NORMAL AGING MILD COGNITIVE IMPAIRMENT AND ALZHEIMERS DISEASE | 191 |
10 BIOLOGICAL MARKERS | 205 |
11 CLINICAL EVALUATION | 229 |
12 TREATMENT OF MILD COGNITIVE IMPAIRMENT AND PROSPECTS FOR PREVENTION OF ALZHEIMERS DISEASE | 243 |
259 | |
Andra upplagor - Visa alla
Mild Cognitive Impairment: Aging to Alzheimer's Disease Ronald C. Petersen Begränsad förhandsgranskning - 2003 |
Vanliga ord och fraser
abnormalities age-related allele allocortex Alzheimer disease Alzheimer's disease amygdala amyloid Ann Neurol apolipoprotein Arch Neurol Aẞ assessment atrophy brain cells cerebral cortex changes Clin clinical clinician cognitive decline cognitive function cognitive test cohort colleagues correlation cortical criteria deficits depression detecting develop diagnosis disorders donepezil E.G. Tangalos early elderly entorhinal cortex evaluation factors G.E. Smith genotype Gómez-Isla hippocampal formation hippocampal volume Hyman imaging increased individuals Kokmen levels limbic lipofuscin longitudinal loop Malec marker Mayo measures medial temporal lobe memory complaints memory impairment mentia metabolism mild cognitive impairment MMSE myelination neocortical Neurobiol Aging neurofibrillary tangles Neurology neuronal neuronal loss neuropathological neuropsychological tests Neurosci normal aging nuclei older adults order sensory association pathology patients perfusion persons plaques predictive prefrontal prodromal progression Psychiatry Psychol R.C. Petersen R.J. Ivnik region Reisberg risk sensitivity sensory association areas somato specific SPECT stage tau protein test scores